Ā | Group I | Group II | Control | P value |
---|---|---|---|---|
Number of subjects | 10 | 10 | 10 | Ā |
Age (years) | 9.7āĀ±ā2.4 | 8.8āĀ±ā2.3 | 9.6āĀ±ā1.7 | Ā |
Gender, n | ||||
āMale | 5 | 4 | 6 | Ā |
āFemale | 5 | 6 | 4 | Ā |
Tumor consolidation, n | ||||
āCryotherapy | 8 | 0 | 0 | Ā |
āTTT | 9 | 0 | 0 | Ā |
āCryotherapy + TTT | 7 | 0 | 0 | Ā |
BCVA (logMAR) | 0 | 0 | 0 | Ā |
Axial Length (mm) | 23.0āĀ±ā1.1 | 22.9āĀ±ā0.8 | 23.1āĀ±ā0.7 | Ā |
First presentation time (mouth) (mouth) | 12.9āĀ±ā7.7 | 30.1āĀ±ā9.6 | Ā | 0.0003 |
Duration time (year) | 8.2āĀ±ā2.4 | 7.3āĀ±ā2.4 | Ā | 0.4127 |
IVC times | 6.5āĀ±ā1.6 | 6.5āĀ±ā1.6 | Ā | 1 |
Family history, n (%) | 1(10%) | 0 | Ā | Ā |